Failure of pharmacological and endoscopic treatments: What is to be done?;Que faire en cas d'échec des traitements pharmacologiques et endoscospique

Gastroenterologie Clinique et Biologique

Volumn 28, Issue SPEC. ISS. 2, 2004, Pages

  Pauwels, Arnaud ^a  

^a CENTRE HOSPITALIER DE GONESSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CONFERENCE PAPER; ESOPHAGUS TRANSECTION; ESOPHAGUS VARICES BLEEDING; HUMAN; LIVER CIRRHOSIS; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; SALVAGE THERAPY; SYSTEMATIC REVIEW; THERAPY RESISTANCE; TREATMENT FAILURE; TREATMENT INDICATION; ACUTE DISEASE; ESOPHAGOSCOPY; ESOPHAGUS DISEASE; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; PORTOSYSTEMIC ANASTOMOSIS; REVIEW; RUPTURE;

ACUTE DISEASE; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGEAL DISEASES; ESOPHAGOSCOPY; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HUMANS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RUPTURE, SPONTANEOUS; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 2442456930     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (82)

1. Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. J Hepatol 2003;38:S54-S68.
2. Ben-Ari Z, Cardin F, McCormick AP, Wannamethee G, Burroughs AK. A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol 1999;31:443-50.
3. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independantly associated with failure to control bleeding in cirrhotic patients with gastrointestinal haemorrhage. Hepatology 1998;27:1207-12.
4. Moitinho E, Escorcell A, Bandi JC, Salmeron JM, Garcia-Pagan JC, Rodès J, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999;117:626-31.
5. de Franchis R. Developing consensus in portal hypertension. J Hepatol 1996;25:390-4.
6. de Franchis R. Updating consensus on portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-52.
7. Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998;28:868-80.
8. Calès P, Castaing D, Grange JD, Lebrec D, Lemoine O, Poynard T, et al. Traitement de l'hypertension portale. Gastroenterol Clin Biol 1999;23: 353-4.
9. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2000;46 (Suppl III): iii1-iii15.
10. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med 2000;345:669-81.
11. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal bleeding, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001;120:726-48.
12. Besson I, Ingrand P, Person B, Boutroux D, Heresbach D, Bernard P, et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;333:555-60.
13. Sung JJY, Chung SCS, Yung MY, Lai CW, Lau JYW, Lee YT, et al. Prospective randomized study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995;346: 1666-9.
14. Calès P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 2001;344:23-8.
15. Terblanche J, Yakoob HI, Bornman PC, Stiegmann GV, Bane R, Jonker M, et al. Acute bleeding varices: a five-year prospective evaluation of tamponade and sclerotherapy. Ann Surg 1981;194:521-30.
16. Burroughs AK, Hamilton G, Phillips A, Mezzanotte G, McIntyre N, Hobbs KE. A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med 1989;321:857-62.
17. Bornman PC, Terblanche J, Kahn D, Jonker MA, Kirsch RE. Limitations of multiple injection sclerotherapy sessions for acute variceal bleeding. S Afr Med J 1986;70:34-6.
18. Carbonell N, Pauwels A, Fourdan O, Serfaty L, Lévy VG, Poupon R. Diminution de la fréquence des récidives hémorragiques précoces après rupture de VO au cours des 2 dernières décennies: rôle des traitements vasoactifs et de la ligature endoscopique. Gastroenterol Clin Biol 2001;25:613.
19. McCormick PA, Dick R, Panagou EB, Chin JKT, Greenslade L, McIntyre N, et al. Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg 1994;81:1324-7.
20. Jalan R, John TG, Redhead DN, Garden OJ, Simpson KJ, Finlayson NDC, et al. A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol 1995; 90:1932-7.
21. Czernichow P, Hochain P, Nousbaum JB, Raymond JM, Rudelli A, Dupas JL, et al. Epidemiology and course of acute upper gastrointestinal haemorrhage in four French geographical areas. Eur J Gastroenterol Hepatol 2000;12:175-81.
22. Kravetz D, Sikuler E, Groszmann RJ. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology 1986;90:1232-40.
23. Hilzenrat N, Arish A, Yaari A, Sikuler E. Acute hemodynamic changes following hemorrhage and volume restitution, using a low viscosity plasma expander, in anesthetized portal hypertensive rats. J Hepatol 1999;31:874-9.
24. Castaneda B, Morales J, Lionetti R, Moitinho E, Andreu V, Pérez-del-Pulgar S, et al. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats. Hepatology 2001;33:821-5.
25. Luca A, Cirera I, Garcia-Pagan JC, Feu F, Pizcueta P, Bosch J, et al. Hemodynamic effects of acute changes in intra-abdominal pressure in patients with cirrhosis. Gastroenterology 1993;104:222-7.
26. Escorcell A, Gines A, Llach J, Garcia-Pagan JC, Bordas JM, Bosch J, et al. Increasing intra-abdominal pressure increases pressure, volume, and wall tension in esophageal varices. Hepatology 2002;36:936-40.
27. Luca A, Feu F, Garcia-Pagan JC, Jimènez W, Arroyo V, Bosch J, et al. Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites. Hepatology 1994;20:30-3.
28. Kravetz D, Romero G, Argonz J, Guevara M, Suarez A, Abecasis R, et al. Total volume paracentesis decreases variceal pressure, size, and variceal wall tension in cirrhotic patients. Hepatology 1997;25:59-62.
29. Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 1995;108:1828-34.
30. Vivas S, Rodriguez M, Palacio A, Linares A, Alonso JL, Rodrigo L. Presence of bacterial infection in bleeding cirrhotic patients is independantly associated with early mortality and failure to control bleeding. Dig Dis Sci 2001;46:2752-7.
31. Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 1999;353:139-42.
32. Bernard B, Grangé JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding. A meta-analysis. Hepatology 1999;29:1655-61.
33. Panés J, Terés J, Bosch J, Rodés J. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutives episodes. Dig Dis Sci 1988;33:454-9.
34. Rudolph SJ, Landsverk BK, Freeman ML. Endotracheal intubation for airway protection during endoscopy for severe upper GI hemorrhage. Gastrointest Endosc 2003;57:58-61.
35. Frossard JL, Spahr L, Queneau PE, Giostra E, Burckhardt B, Ory G, et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology 2002;123:17-23.
36. Coffin B, Pocard M, Panis Y, Riche F, Laine MJ, Bitoun A, et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointest Endosc 2002;56:174-9.
37. Lo GH, Lai KH, Cheng JS, Lin CK, Huang JS, Hsu PI, et al. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology 1997;25:1101-4.
38. Rösch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 1969; 92:1112-4.
39. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, et al. Creation of transjugular intrahepatic portosystemic shunts with the Wallstent endoprosthesis: results in 100 patients. Radiology 1993;187:413-20.
40. Helton WS, Belshaw A, Althaus S, Park S, Coldwell D, Johansen K. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg 1993;165:566-71.
41. Rössle M, Haag K, Ochs A, Sellinger M, Nöldge G, Perarnau JM, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. New Engl J Med 1994;330:165-71.
42. Le Moine O, Devière J, Ghysels M, François E, Rypens F, Van Gansbeke D, et al. Transjugular intrahepatic portosystemic stent shunt as a rescue treatment after sclerotherapy failure in variceal bleeding. Scand J Gastroenterol 1994;29 Suppl 207:23-8.
43. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffman ML, Tisnado J, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996;111:138-46.
44. Jabbour N, Zajko AB, Orons PD, Irish W, Bartoli F, Marsh WJ, et al. Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. Liver Transpl Surg 1996;2: 139-47.
45. Banares R, Casado M, Rodriguez-Laiz JM, Camunez F, Matilla A, Echenagusia A, et al. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol 1998;93:75-9.
46. Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M. Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension. Comparison of emergency and elective-interventions. Dig Dis Sci 1998;43:2463-9.
47. Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. « Salvage » transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998;114:981-7.
48. Williams D, Waugh R, Gallagher N, Perkins K, Dilworth P, Duggan A, et al. Mortality and rebleeding following transjugular intrahepatic portosystemic stent shunt for variceal haemorrhage. J Gastroenterol Hepatol 1998;13:163-9.
49. Barange K, Péron JM, Imani K, Otal P, Payen JL, Rousseau H, et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999;30: 1139-43.
50. Azoulay D, Castaing D, Majno P, Saliba F, Ichaf P, Smail A, et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001;35:590-7.
51. Bizollon T, Dumortier J, Jouisse C, Rode A, Henry L, Boillot O, et al. Transjugular intra-hepatic portosystemic shunt for refractory variceal bleeding. Eur J Gastroenterol Hepatol 2001;13:369-75.
52. Brensing KA, Raab P, Textor J, Görich J, Schiedermaier P, Strunk H, et al. Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis. Eur J Gastroenterol Hepatol 2002;14:723-31.
53. Domagk D, Patch D, Dick R, Grosso M, Rousseau H, Otal P, et al. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using Memotherm stents: a prospective multicenter study. Cardiovasc Intervent Radiol 2002;25:506-12.
54. Bosch J. Salvage transjugular intrahepatic portosystemic shunt: is it really life-saving? J Hepatol 2001;35:658-60.
55. Patch D, Nikolopoulou V, McCormick A, Dick R, Armonis A, Wannamethee G, et al. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol 1998;28:454-60.
56. Rösch J, Keller FS. Transjugular intrahepatic portosystemic shunt: present status, comparison with endoscopic therapy and shunt surgery, and future prospectives. Word J Surg 2001;25:337-46.
57. Castaing D, Azoulay D, Smail A, Adam R, Saliba F, Ichai P, et al. Intérêt d'un protocole de suivi sur la perméabilité à long terme des anastomoses porto-cave transjugulaires (TIPS). Gastroenterol Clin Biol 2003;27: A139.
58. Bureau C, Otal P, Garcia-Pagan JC, Pomier-Layrargues G, Chabbert V, Cortez C, et al. L'utilisation de prothèses couvertes en polytétrafluoroéthylène diminue considérablement le taux d'obstruction des TIPS: résultats d'une étude randomisée multicentrique internationale (résumé). Gastroenterol Clin Biol 2002;26:752.
59. Durtschi MB, Carrico CJ, Johansen KH. Esophageal transection fails to salvage high-risk cirrhotic patients with variceal bleeding. Am J Surg 1985;150:18-23.
60. Jenkins SA, Shields R. Variceal haemorrhage after failed injection sclerotherapy: the role of emergency oesophageal transection. Br J Surg 1989;76:49-51.
61. McCormick PA, Kaye GL, Greenslade L, Cardin F, Hobbs KEF, McIntyre N, et al. Esophageal staple transection as a salvage procedure after failure of acute injection therapy. Hepatology 1992;15:403-6.
62. Sarfeh IJ, Carter JA, Welch HF. Analysis of operative mortality after portal decompressive procedures in cirrhotic patients. Am J Surg 1980;140:306-11.
63. Levine BA, Gaskill HV III, Sirinek KR. Portasystemic shunting remains the procedure of choice for control of variceal hemorrhage. Arch Surg 1985;120:296-300.
64. Soutter DI, Langer B, Taylor BR, Greig P. Emergency portasystemic shunting in cirrhotics with bleeding varices - a comparison of portacaval and mesocaval shunts. HPB Surg 1989;1:107-16.
65. Spina GP, Santambrogio R, Opocher E, Gagliano G, Cucchiaro G, Pisani A, et al. Emergency portosystemic shunt in patients with variceal bleeding. Surg Gynecol Obstet 1990;171:456-63.
66. Rikkers LF, Jin G. Emergency shunt. Role in the present management of variceal bleeding. Arch Surg 1995;130:472-7.
67. Hillebrand DJ, Kojouri K, Cao S, Runyon BA, Ojogho O, Conception W. Small-diameter portacaval H-graft shunt: a paradigm shift back to surgical shunting in the management of variceal bleeding in patients with preserved liver function. Liver Transpl 2000;6:459-65.
68. Pauwels A, Carbonell N, Fourdan O, Lévy VG, Poupon R. Mortality of cirrhotic patients with gastrointestinal hemorrhage has been greatly reduced in two decades (abstract). J Hepatol 2002;35 (Suppl 1): 208.
69. Rikkers LF, Jin G. Surgical management of acute variceal hemorrhage. World J Surg 1994;18:193-9.
70. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology 2002;35:1282-4.
71. Shellman RG, Fulkerson WJ, DeLong E, Piantadosi CA. Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit. Crit Care Med 1988;16:671-8.
72. Castera L, Pauwels A, Lévy VG. Indicateurs pronostiques chez les malades atteints de cirrhose admis en service de Réanimation. Gastroenterol Clin Biol 1996;20:263-8.
73. Cooper GS, Bellamy P, Dawson NV, Desbiens N, Fulkerson WJ Jr, Goldman L, et al. A prognostic model for patients with end-stage liver disease. Gastroenterology 1997;112:1278-88.
74. Aggarwal A, Ong JP, Younossi ZM, Nelson DR, Hoffman-Hogg L, Arroliga AC. Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest 2001;119:1489-97.
75. Moreau R, Sicot C. Evaluation du pronostic à court terme des cirrhotiques admis en réanimation, à l'aide de 4 índices de gravité. Gastroenterol Clin Biol 1985;9:871-6.
76. Melchior JC, Poupon RE, Verrier J, Merrer J, Moncorge C, Simon N. Analyse des facteurs liés à la mortalité précoce au cours des hémorragies digestives liées à l'hypertension portale. Gastroenterol Clin Biol 1987;11:402-6.
77. Zimmerman JE, Wagner DP, Seneff MG, Becker RB, Sun X, Knaus WA. Intensive care unit admissions with cirrhosis: risk-stratifying patient groups and predicting individual survival. Hepatology 1996;23: 1393-401.
78. Zauner CA, Apsner RC, Kranz A, Kramer L, Madl C, Schneider B, et al. Outcome prediction for patients with cirrhosis of the liver in a medical ICU: a comparison of the APACHE scores and liver-specific scoring systems. Intensive Care Med 1996;22:559-63.
79. Butt AK, Khan AA, Alam A, Shah SW, Shafgat F, Naqvi AB. Predicting hospital mortality in cirrhotic patients: comparison of Child-Pugh and Acute Physiology, Age and Chronic Health Evaluation (APACHE HI) scoring systems. Am J Gastroenterol 1998;93:2469-75.
80. Afessa B, Kubilis PS. Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction. Am J Gastroenterol 2000;95:484-9.
81. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg 1985;202:685-93.
82. Wehler M, Kokoska J, Reulbach U, Hahn EG, Strauss R. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology 2001;34:255-61.